Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Oncogene|July 27, 2004
Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancerMilo Frattini, Cristina Ferrario, Paola Bressan, et al.
Nature Communications|August 24, 2023
A qPCR technology for direct quantification of methylation in untreated DNAKamilla Kolding Bendixen, Maria Mindegaard, Samantha Epistolio, et al.
Cancers|December 30, 2025
A Real-World Experience on the Efficacy of First-Line Treatment with Immune-Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Patients with PD-L1 Expression ≥50%: The Role of <i>KRAS</i> MutationsLucia Motta, Samantha Epistolio, Jana Pankovics, et al.
Journal of Clinical Medicine|July 29, 2025
Prognostic Impact of KRAS-TP53 Co-Mutations in Patients with Early-Stage Non-Small Cell Lung Cancer: A Single-Center Retrospective StudyLucia Motta, Francesca Molinari, Jana Pankovics, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2021
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid TumorsIlaria Colombo, Sofia Genta, Federica Martorana, et al.
Oncology Reports|July 14, 2005
FGFR4 Gly388Arg polymorphism and prognosis of breast and colorectal cancerMonica Spinola, Vera Piera Leoni, Jun-Ichi Tanuma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2012
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumorsClaudia Miranda, Martina Nucifora, Francesca Molinari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2014
ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practiceVittoria Martin, Barbara Bernasconi, Elisabetta Merlo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutationsMilo Frattini, Ileana Carnevali, Stefano Signoroni, et al.
Glycobiology|April 30, 2015
NEU3 activity enhances EGFR activation without affecting EGFR expression and acts on its sialylation levelsAlessandra Mozzi, Matilde Forcella, Alice Riva, et al.
Pageof 10